Trans-Atlantic private equity healthcare specialist ArchiMed has made the first exit from its MED II fund with the sale of Austria-based medical technology company EUROLyser to Antech Diagnostics, a provider of diagnostic and imaging solutions for the veterinary industry, in the US. Antech is part of Mars Veterinary Health. Financial terms were not revealed….
©2023 All rights reserved LaingBuisson 
